Evidence map›Paper›PMID 29246180›Full record

ArticleParasites & vectors2017

Lipophosphoglycan polymorphisms do not affect Leishmania amazonensis development in the permissive vectors Lutzomyia migonei and Lutzomyia longipalpis.

Paula M Nogueira, Agna C Guimarães, Rafael R Assis, Jovana Sadlova, Jitka Myskova, Katerina Pruzinova, Jana Hlavackova, Salvatore J Turco, Ana C Torrecilhas, Petr Volf and 1 more

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. LABCG1 AffectsACS infectious diseases · 2026
    Article
  2. Review
  3. Virulence · 2025
    Article
  4. Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2024
    Review
  5. Molecular Detection ofTropical medicine and infectious disease · 2024
    Article
  6. Phenotypical Differences betweenPathogens (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Lipophosphoglycan From Dermotropic New WorldFrontiers in cellular and infection microbiology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Intraspecies Polymorphisms in the Lipophosphoglycan ofFrontiers in cellular and infection microbiology · 2019
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Paula M NogueiraInstituto René Rachou/FIOCRUZ, Belo Horizonte, MG, Brazil. paulamn.bio@gmail.com.
Agna C GuimarãesDepartamento de Parasitologia, UFMG, Belo Horizonte, MG, Brazil.
Rafael R AssisInstituto René Rachou/FIOCRUZ, Belo Horizonte, MG, Brazil.
Jovana SadlovaDepartment of Parasitology, Faculty of Science, Charles University, Prague, Czech Republic.
Jitka MyskovaDepartment of Parasitology, Faculty of Science, Charles University, Prague, Czech Republic.
Katerina PruzinovaDepartment of Parasitology, Faculty of Science, Charles University, Prague, Czech Republic.
Jana HlavackovaDepartment of Parasitology, Faculty of Science, Charles University, Prague, Czech Republic.
Salvatore J TurcoDepartment of Biochemistry, University of Kentucky Medical Center, Lexington, KY, USA.
Ana C TorrecilhasLaboratório de Imunologia Celular e Bioquímica de Fungos e Protozoários, Departamento de Farmácia, UNIFESP, São Paulo, SP, Brazil.
Petr VolfDepartment of Parasitology, Faculty of Science, Charles University, Prague, Czech Republic.
Rodrigo P SoaresInstituto René Rachou/FIOCRUZ, Belo Horizonte, MG, Brazil.
Charles University · CZFundação Oswaldo Cruz · BRUniversidade Federal de Minas Gerais · BRUniversidade Federal de São Paulo · BRUniversity of Kentucky · US

Funding

Chales University UNCE 204017/2012Fundação de Amparo à Pesquisa do Estado de Minas Gerais PPM-00102-16Fundação de Amparo à Pesquisa do Estado de São Paulo FAPESP 2016-01917-3
6 · The paper itself

Abstract

backgroundLipophosphoglycan (LPG) is a dominant surface molecule of Leishmania promastigotes. Its species-specific polymorphisms are found mainly in the sugars that branch off the conserved Gal(β1,4)Man(α1)-PO

resultsStrains isolated from Lutzomyia flaviscutellata (PH8) and from a human patient (Josefa) displayed structural polymorphism in the LPG repeat units, possessing side chains with 1 and 2 β-glucose or 1 to 3 β-galactose, respectively. Both strains successfully infected permissive vectors Lutzomyia longipalpis and Lutzomyia migonei and could colonize their stomodeal valve and differentiate into metacyclic forms. Despite bearing terminal galactose residues on LPG, Josefa could not sustain infection in the restrictive vector Phlebotomus papatasi.

conclusionsLPG polymorphisms did not affect the ability of Le. amazonensis to develop late-stage infections in permissive vectors. However, the non-establishment of infection in Ph. papatasi by Josefa strain suggested other LPG-independent factors in this restrictive vector.

Indexed as

AnimalsGlycosphingolipidsHumansLeishmaniaPsychodidaeGlycosphingolipidslipophosphonoglycanLeishmania amazonensisLipophosphoglycanLutzomyia longipalpisLutzomyia migoneiPhlebotomus papatasiVector-parasite interaction

Identifiers

PMID29246180
PMCPMC5732482
OpenAlexW2775192030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.